CDC Distributors, Inc. – Trademark Portfolio
Entity Type: 03
CDC Distributors, Inc. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 19 (Building Materials) — 7 filings in this category. The portfolio also extends into Class 27 (Floor Coverings) across 4 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include IRRESISTIBLE, GRAND COLLECTION, TIMELESS DESIGNS, and IRRESISTIBLE COLLECTION. The owner is based in Cincinnati, OH.
10511 Medallion Drive
Cincinnati, OH 45241
Showing of trademarks Trademarks
Trademark Classifications
CDC Distributors, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Building materials (non-metallic); non-metallic rigid pipes for building
Carpets, rugs, mats and matting, linoleum and other materials for covering floors
Frequently Asked Questions
How many trademarks does CDC Distributors, Inc. have?
CDC Distributors, Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 6 registered, 2 abandoned, 1 cancelled.
What trademark classes does CDC Distributors, Inc. file in?
CDC Distributors, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 19 (Building Materials), Class 27 (Floor Coverings), Class 1 (Chemicals), Class 20 (Furniture). Class 19 covers building materials (non-metallic); non-metallic rigid pipes for building.
What are CDC Distributors, Inc.'s most well-known trademarks?
CDC Distributors, Inc.'s registered trademark portfolio includes well-known marks such as IRRESISTIBLE, GRAND COLLECTION, TIMELESS DESIGNS, and IRRESISTIBLE COLLECTION. These are among 6 currently registered trademarks in the portfolio.
What is CDC Distributors, Inc.'s trademark registration success rate?
CDC Distributors, Inc. has a 67% trademark registration rate, with 6 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.